Human Noggin/NOG, Tag Free Protein
Usd: 159 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_HA210726_Europe.pdf
- No MSDS Found
Product Information
Product name
Human Noggin/NOG, Tag Free Protein
Catalog No.
HA210726
Predicted molecular mass
23.1 kD
Protein construction description
A DNA sequence encoding the human Noggin/NOG protein (Q13253) (Gln 28-Cys 232) was expressed with tag free.
Accession
Q13253
Protein construction
Source
HEK293
Purity
>95% as determined by SDS-PAGE.
Endotoxin
Less than 1.0 EU per μg by the LAL method.
Formulation
Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4, 5% Trehalose, 5% mannitol.
Species
Human
Background
The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse.
Usage guide
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped with blue ice. Bulk packages of recombinant proteins are provided as frozen liquid which are shipped with dry ice.
Storage
Please avoid repeated freeze-thaw cycles. Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃ It is recommended that aliquot the reconstituted solution to minimize freeze-thaw cycles.
Reconstitution
Reconstitute at 250 μg/ml in sterile water.
Products with the same target and pathway
Human Thrombospondin-1/THBS1, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human ALK-7, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human MAPK1/ERK2, C-His Tag Protein
Application:
Reactivity: Human
Conjugate:
Human TGF-Beta 1 / TGFB1, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human Follistatin, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human phosphorylated MAPK1/ERK-2 (pT185 and pY187) Protein
Application:
Reactivity: Human
Conjugate:
Human INHBE, N-His Tag Protein
Application:
Reactivity: Human
Conjugate:
Human IFN-gamma, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human BMP-2, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human TNF-alpha, C-His Tag Protein
Application:
Reactivity: Human
Conjugate:
Human TNF-alpha, Tag Free Protein
Application:
Reactivity: Human
Conjugate:
Human TGF-beta RII, Tag Free (ECD) Protein
Application:
Reactivity: Human
Conjugate:
Human IFN-gamma, C-His Tag Protein
Application:
Reactivity: Human
Conjugate: